CAROLINE Y. GOODMAN is a Research Analyst at BlueStone Capital Partners.
She is associated with the Medical Technologies and Life Sciences Group,
focusing on the biotechnology sector. Prior to joining BlueStone Capital
Partners, Ms. Goodman was a Research Analyst for the Salomon Smith
Barney Consulting Group, where she was responsible for proprietary
research and evaluation of institutional money managers and no-load
mutual funds. Ms. Goodman began her career in finance as an Analyst at
Weston Financial Group in Wellesley, Massachusetts. Prior to that, she
held a position as a Research Chemist with Armstrong Laboratories. Ms.
Goodman received a BA in Chemistry from Barnard College of Columbia
University and both an MS in Chemistry and an MS in Molecular and Cell
Biology from Brandeis University.